Analyst Coverage

Investors

print email

Viking Therapeutics, Inc. is covered by the following analysts:

H.C. Wainwright & Co.   Joseph Pantginis, Ph.D.          646-975-6968
Laidlaw & Company (UK) Ltd Yale Jen, Ph.D. 212-953-4978
Maxim Group Jason McCarthy, Ph.D.  212-895-3556
Roth Capital Partners Scott Henry, CFA 949-500-0863
William Blair & Company Andy Hsieh, Ph.D. 312-364-5051
Zacks Investment Research, Inc.          David Bautz, Ph.D. 312-265-9471

 

 

 

 

 


Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent Viking Therapeutics or its management team. Viking Therapeutics is under no obligation to update this list, thus it may not be complete or up to date.